[APLS] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -142.99%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 75,422 66,563 250,646 0 0 0 0 -
PBT -651,503 -746,002 -343,029 -304,707 -127,502 -51,006 -27,125 69.81%
Tax 669 352 1,845 5,109 -533 251 -27,282 -
NP -652,172 -746,354 -344,874 -309,816 -127,502 -51,006 -27,125 69.84%
Tax Rate - - - - - - - -
Total Cost 727,594 812,917 595,520 309,816 127,502 51,006 27,125 72.97%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -864.70 -1,121.27 -137.59 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -6.15 -8.84 -4.59 -4.98 -2.34 -3.68 -1.50 26.49%
EPS Diluted -6.15 -8.84 -4.59 -4.98 -2.34 -3.68 -1.50 26.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.